Quick Links

Home Page

McGill University Research Centre on Complex Traits

An Initiative to Cure Infectious and Chronic Inflammatory Diseases

McGill’s Complex Traits Group created in 2008 is now officially a Centre:
the McGill University Research Centre on Complex Traits – MRCCT.


The mission of the MRCCT is to establish a multidisciplinary Center of excellence in research and education that will accelerate new scientific discoveries, enabling personalized translational medicine to better prevent and treat infectious and chronic inflammatory diseases.

We are really excited at the prospect of working to understand the genetic and molecular underpinnings of immunity-related diseases, and to implement innovative platforms to translate research results into information of potential clinical value. The MRCCT brings together colleagues (International, national and local researchers) whose interests in disease range from genetic susceptibility to molecular mechanisms to clinical treatment. We are very confident that MRCCT will provoke an enormous increase in innovative thinking and scientific productivity that can only result from sharing technologies, lab meetings, seminar series and retreats.  We envision the MRCCT to be an incubator of talent and inventions that will lead to new solutions for infectious and chronic inflammatory diseases. 

Our Mission

The mission of the MRCCT is to establish a multidisciplinary Center of excellence in research and education that will accelerate new scientific discoveries, enabling personalized translational medicine to better prevent and treat infectious and chronic inflammatory diseases.

  • PROVIDE
    Innovative platforms to harness opportunities from emerged genomic information to elucidate the molecular pathophysiology of infectious and inflammatory diseases.
     
  • TRAIN
    A new generation of scientists with multidisciplinary expertise in genetics, genomics, immunology, cell biology, biochemistry and bioinformatics.
     
  • TRANSLATE
    Basic science results from the bench to the bedside through collaborations with clinicians and clinician scientists, the pharmaceutical sector and the community.